Ask AI
CAMMA 1 Updated Analysis
CAMMA 1: Updated Safety, Efficacy, and Biomarker Analyses From Phase I Study of Cevostamab + Pomalidomide + Dexamethasone in BCMA1-Naive RRMM

Released: December 09, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 09, 2025